Navigation Links
Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
Date:11/10/2008

Conference Call Scheduled for November 11, 2008 at 9:00 am ET

SOUTH SAN FRANCISCO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that the ACTIVE-1 Phase 3 trial evaluating Adlea(TM), a novel formulation of capsaicin, narrowly missed its primary endpoint of reducing post-surgical pain versus placebo (p=0.07) following bunionectomy surgery at four to 32 hours post-surgery. The same measure was highly significant (p=0.004) from four to 48 hours post-surgery. The trial also achieved a key secondary endpoint of reducing opioid use for Adlea versus placebo (p=0.012) over the four to 32 hour period. Adverse events were similar for both active treatment and placebo groups. Results of a second Phase 3 trial of Adlea, in total knee replacement surgery, will be announced next month.

"It is important to note that the four to 32 hour pain measure reflected the inpatient period where activity is most restricted," said William Houghton, M.D., Anesiva senior vice president and chief medical officer. "In contrast, non-weight bearing mobilization increased during the latter period. Thus, the longer duration four to 48 hour measure highlights important analgesic potential for Adlea. We expect this to be confirmed in the upcoming ACTIVE-2 total knee arthroplasty study which uses the same four to 48 hour analgesic measure as its primary endpoint."

Anesiva has determined that it will cease further commitments to support Zingo commercialization as a result of continued manufacturing challenges and the need to recall product in the field due to a potential non-safety related shelf life issue from a lot of unreleased product. Anesiva plans to seek a device-oriented partner for this asset. The compan
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
2. Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
3. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
4. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
5. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
6. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
7. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
8. Anesiva Defines Regulatory Pathway for Adlea with FDA
9. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
10. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015  Intec Pharma Ltd. (the "Company") (NASDAQ: ... on developing drugs based on its proprietary Accordion Pill ... public offering in the United States ... price to the public of $6.00 per ordinary share, ... shares are being offered by the Company.  In addition, ...
(Date:8/4/2015)... Aug. 4, 2015 Concord Medical Services Holdings Limited ... hospital management solution provider and operator of the largest network ... , today announced it will release its financial results ... on August 17, 2015. Management will hold a ... 8:00 a.m. EDT on August 18, 2015 (8:00 p.m. in ...
(Date:8/4/2015)... , Aug. 4, 2015 BioElectronics ... over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical devices, announced ... of its ActiPatch 7-day trial device has been ... Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More ... survey and submitted an assessment.  ...
Breaking Medicine Technology:Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2
(Date:8/4/2015)... ... ... Journal of Pain Research has published the review “ The Association between ... obesity and chronic pain are serious public health concerns in our society. They also ... there appear to be multiple factors that contribute to each of these conditions. It ...
(Date:8/4/2015)... ... August 04, 2015 , ... World Patent ... Dumbbell Bench Rack, a fitness invention that eliminates the need to have a ... and Fitness Clubs industry is worth $30 billion," says Scott Cooper, CEO and ...
(Date:8/4/2015)... ... 04, 2015 , ... assistPoint Partners, LLC is proud ... patient assistance programs. Through a secure web portal, assistPoint connects Life Sciences, Patients ... level, cloud-based application and workflow solution. This provides cancer center patient advocates, financial ...
(Date:8/4/2015)... ... 2015 , ... The United Nations Foundation today announced a ... for a select group of U.S.-based journalists during the week of November 9, ... International Conference on Family Planning in Bali. , In close coordination with ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... electrocardiogram (EKG), echocardiogram, and NCV testing, announced their collegiate division, Wimbledon U ... undiagnosed cardiovascular abnormalities one program at a time. , “Wimbledon U ...
Breaking Medicine News(10 mins):Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:assistPoint.com Web Site Launched 2Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3
... that researchers have found a way to reverse muscular dystrophy ... cure for the human form of the disease may be ... therapy used by them could fully restore heart and skeletal ... of principle for a therapeutic strategy for treatment of myotonic ...
... smoking has revealed that nicotine dependence can develop in ... they become regular users.// Smoking cessation programs for ... to be integrated into the cessation programs aimed at ... natural course of cigarette use has traditionally been thought ...
... in large parts of north India, encephalitis has once again ... virus has already claimed the lives of 36 children, officials ... virus was not the deadly Japanese encephalitis, they do not ... ,"So far, we have not detected Japanese encephalitis in ...
... Hyderabad-based Aurobindo Pharma Ltd today said it has ... fixed drug combination product used for anti-HIV treatment. ... contains Lamivudine 150mg+2idovudine300mg tablets co-packaged with Abacavir 300mg ... ,This combination pack enhances convenience, is cost-effective ...
... AIDS in the district in past two months while seven new ... // ,This month alone, seven new HIV positive cases ... in the past two months, Chief Medical Superintendent Rajni Kant Gupta ... risen to 58 of which 30 of the infected were between ...
... of smoking and a former 100-cigarette-a-day user, from Britain has ... ,Allen Carr has written a number of extremely ... unhealthy habit, had earlier today confirmed his illness. A ... ago I have been the happiest man in the world. ...
Cached Medicine News:Health News:36 Children Die of Encephalitis in Uttar Pradesh 2
... Manager is the most ... critical care data management ... PDM is an ... to effortlessly manage all ...
... the wall-mounted organizer with a complete set of ... diameters. The Micro Nest makes it easier for ... cleaning task. These small instrument cleaning brushes from ... such as cannulas. ISI Micro Brushes are available ...
... Instra-Glide Target is the non-silicone lubricant ... , ,Instra-Glide Target lubricates sticky pivot points, ... The penetration straw allows you to lubricate ... and painted surfaces. Ideal for carts, hinges, ...
... Hemaway Original attacks dried blood, tissue, ... in hard to reach places such as ... reducing the need for scrubbing. Hemaway Original ... but gentle enough to be used everyday. ...
Medicine Products: